Self-Assembled Surfactant-Polyoxovanadate Soft Materials as Tuneable Vanadium Oxide Cathode Precursors for Lithium-Ion Batteries

The mixing of [V₁₀O₂₈]⁶⁻ decavanadate anions with a dicationic gemini surfactant ( gem ) leads to the spontaneous self-assembly of surfactant-templated nanostructured arrays of decavanadate clusters. Calcination of the material under air yields highly crystalline, sponge-like V₂O₅ ( gem -V₂O₅ ). In contrast, calcination of the amorphous tetrabutylammonium decavanadate allows isolation of a more agglomerated V₂O₅ consisting of very small crystallites ( TBA -V₂O₅ ). Electrochemical analysis of the materials’ performance as lithium-ion intercalation electrodes highlights the role of morphology in cathode performance. The large crystallites and long-range microstructure of the gem -V₂O₅ cathode deliver higher initial capacity and superior capacity retention than TBA -V₂O₅ . The smaller crystallite size and higher surface area of TBA -V₂O₅ allow faster lithium insertion and superior rate performance to gem -V₂O₅ .     

Simple and rapid determination of clonidine in pharmaceutical samples by voltammetry using a bare glassy carbon electrode

This work presents, for the first time, the voltammetric behavior of clonidine (CLO) drug and its determination, using an unmodified glassy carbon electrode (GCE). CLO exhibited only an irreversible oxidation process on the GCE, with peak potential at +0.85 V in pH 12 (vs Ag/AgCl). CLO oxidation process is pH-dependent and the electrochemical mechanisms on the GCE were proposed in acidic and basic medium. The determination of CLO was optimized in 0.1 mol L⁻¹ phosphate buffer solution at pH 12.0 using differential pulse voltammetry (DPV), which provides a good linear range (0.65 to 106.00 μmol L⁻¹) and low theoretical limit of detection (0.14 μmol L⁻¹) for the quality control of this drug in pharmaceutical samples. In addition, stable responses of CLO at the GCE were obtained in the same day (RSD = 3.4 %; n = 5) and different days (RSD = 2.0 %; n = 3). Moreover, the determination of CLO in a pharmaceutical formulation using the proposed GCE-DPV method presented good accuracy, since the recovery was close to 100 % and the dosing result was in agreement with an official method (HPLC-UV). The proposed method demonstrates a good analytical performance for CLO determination in pharmaceutical samples, providing a faster, simpler and lower-cost alternative for quality control of CLO than other reported methods.